Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Liminal BioSciences (LMNL)
NASDAQ:LMNL
Holding LMNL?
Track your performance easily
LMNL Stock Chart & Stats
Day’s Range$8.48 - $8.5
52-Week Range― - ―
Previous Close$8.49
Volume5.09K
Average Volume (3M)N/A
Market Cap
$27.62M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Liminal BioSciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LMNL FAQ
What was Liminal BioSciences’s price range in the past 12 months?
Currently, no data Available
What is Liminal BioSciences’s market cap?
Currently, no data Available
When is Liminal BioSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Liminal BioSciences’s earnings last quarter?
Currently, no data Available
Is Liminal BioSciences overvalued?
According to Wall Street analysts Liminal BioSciences’s price is currently Overvalued.
Does Liminal BioSciences pay dividends?
Liminal BioSciences does not currently pay dividends.
What is Liminal BioSciences’s EPS estimate?
Liminal BioSciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Liminal BioSciences have?
Currently, no data Available
What happened to Liminal BioSciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Liminal BioSciences?
Currently, no hedge funds are holding shares in LMNL
---
Liminal BioSciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Liminal BioSciences
Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment offers prometic's core bioseparation technologies and products. The Plasma-derived Therapeutics segment provides efficient extraction and purification of therapeutic proteins from human plasma. The Small Molecule Therapeutics segment manufactures drug candidates such as PBI-4050, PBI-4547, and PBI-4425. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.
---
Technical Analysis
---